mso
mso · page 2
- Adult-Use
Analysts say these Canadian weed stocks could rebound post-legalization
US Senate Majority Leader Schumer’s bill is unlikely to be passed, but it’s a good starting point for negotiations, said Owen Bennett, senior vice president of global tobacco and cannabis stocks at Jefferies Equity Research, on BNN Bloomberg.
- Cannabis Daily News
Jefferies is betting on these U.S. weed stocks
New York-based investment banking company Jefferies Group is initiating coverage of seven U.S. pot stocks — Curaleaf, Green Thumb, Trulieve, Cresco, Columbia Care, TerrAscend and Ayr Strategies — and upgraded them all to a “buy” rating, reports BNN Bloomberg.
- Uncategorized
Canadian ETFs are riding high — thanks to the US
In the last year, cannabis ETFs Purpose and Horizons have returned 157.42% and 136.36% respectively, which is significantly higher than big funds like the ARK Innovation ETF, according to Morningstar.
- Adult-Use
Curaleaf on the fast track to growth
Wakefield, Massachusetts-based Curaleaf reported record earnings for Q1 this week at US$260 million, up 170% year over year.
- Adult-Use
Trulieve snaps up Harvest Health for mega-MSO
In what they’re calling the largest American cannabis deal in history, Florida’s Trulieve announced its plans to acquire Arizona-based Harvest Health in an all-stock deal valued at approximately US$2.1 billion.
- Adult-Use
Wall Street picks MSOs over Canada
Despite good news like New York legalization and the SAFE banking act advancing, the cannabis capital market haven’t rebounded all the way, reports MarketWatch.
- Adult-Use
The ‘Wolf of Weed Street’ bets against Canada
Cannabis stock analyst Jason Spatafora, a.k.a. the Wolf of Weed Street, had harsh predictions for debt-strapped Canadian public companies banking on survival in the US.
- Your #1 Podcast on Cannabis News
Mert Guler, Purves Redmond Limited and Stephen Scardello, USI
On this episode – BofC Live features a conversation with Mert Guler of Purves Redmond Ltd. and Stephen Scardello of USI talking about cannabis in the insurance sector, in both Canada and the US.
